Related Experiment Video
Updated: Aug 25, 2026
Isolation and Genetic Manipulation of Adult Cardiac Myocytes for Confocal Imaging
Published on: September 17, 2009
Gene transfer in cardiac myocytes
Babar B Chaudhri1, Federica del Monte, Sian E Harding
1Imperial College, London, UK.
Abstract:
Congestive heart failure (CHF) represents an enormous clinical problem and remains a leading cause of death despite advances in treatment. New treatments significantly impact mortality and disease course; they do not cure the underlying pathology. Gene transfer, the ability to genetically reprogram the heart in relevant cardiovascular disease models, allows testing the role of specific molecular pathways in disease pathogenesis. Potential therapeutic intervention targets can be then identified and approached with the full spectrum of therapeutic options, including traditional pharmacology, targeted synthesis of small molecule agonists or antagonists, biological agents (cells, antibodies, genetic material), or gene-based therapy. Lessons gleaned from gene transfer experiments on local modulation of cardiac genetic programs will guide attempts to transform early investigations into established therapy.
Insights
Gene transfer offers a novel approach to understanding and treating congestive heart failure (CHF). This method allows for genetic reprogramming of the heart, identifying new therapeutic targets for CHF.
Area of Science:
- Cardiovascular Research
- Molecular Biology
- Gene Therapy
Background:
- Congestive heart failure (CHF) is a major cause of mortality despite current treatments.
- Existing therapies manage CHF but do not cure the underlying pathology.
Purpose of the Study:
- To explore gene transfer as a method for genetically reprogramming the heart.
- To identify specific molecular pathways involved in cardiovascular disease pathogenesis.
- To discover potential therapeutic targets for CHF.
Main Methods:
- Utilizing gene transfer in cardiovascular disease models.
- Testing the role of specific molecular pathways in disease development.
- Identifying potential therapeutic intervention targets.
Main Results:
- Gene transfer enables the genetic reprogramming of the heart.
- This approach facilitates the investigation of molecular pathways in disease.
- Potential therapeutic targets for CHF can be identified.
Conclusions:
- Gene transfer is a valuable tool for studying CHF pathogenesis.
- Lessons from gene transfer will guide the development of new CHF therapies.
- This approach may transform early investigations into established treatments.
